Blog
Have a Roth IRA? Steer Clear of This Pitfall
When it comes to building your retirement nest egg, you have choices. You could opt to save for your later years in a traditional IRA. Doing so gives you a tax break on your contributions on top of
This Ultra-High-Yielding Dividend Stock Continues to Take Steps to Get Healthy Again
Medical Properties Trust (NYSE: MPW) has one primary goal these days: It wants to get back to full financial health. The real estate investment trust (REIT) has undertaken a series of moves to
A Bull Market Is Coming: 2 Remarkable Growth Stocks to Buy Before They Soar 200% by 2028
The S&P 500 (SNPINDEX: ^GSPC) is roughly 9.3% below its all-time high, and therefore 9.3% away from once again trading in bull market territory (using the most conservative definition of a bull
Want Decades of Passive Income? 3 Stocks to Buy Now
Rising interest rates have put pressure on the utility sector, which generally competes for dollars with other income-oriented investments. Basically, when you can buy a certificate of deposit (CD)
Here's My Top Value Stock to Buy Right Now
It may be a no-brainer to buy what Berkshire Hathaway (NYSE: BRK.A)(NYSE: BRK.B) CEO Warren Buffett's buying. Doesn't this necessarily mean investors ought to sell whatever the Oracle of Omaha is
56% of Warren Buffett's $341 Billion Portfolio Is Invested in These 2 Stocks
Few people have the ability to captivate the attention of professional and everyday investors quite like billionaire Warren Buffett. Since becoming CEO of conglomerate Berkshire Hathaway (NYSE:
Altria Stock: Buy, Sell, or Hold?
Shareholders in tobacco company Altria Group (NYSE: MO) recently got paid their quarterly dividend of $0.98 per share. Altria's been putting money in investors' pockets for decades, and the stock's
2 Magnificent Stocks Down 29% and 92% to Buy Before 2024 Arrives
Rising interest rates have been a key economic theme over the last two years as the Federal Reserve continues to fight inflation, which hit a 40-year high in June 2022. It sent the stock market
Bargain Hunting in Dividend Stocks: Down 42%, Is This Former Winner a Buy Again?
On Sept. 13, Motley Fool contributors Jason Hall and Tyler Crowe made a video pointing out some concerns for NextEra Energy (NYSE: NEE). Its shares are down more than 20% since then, continuing a
Social Security: 2 Crucial Tax Rules You Need to Know
Social Security is a lifeline for millions of older adults, but there's a chance you may not receive as much as you're expecting. Even in retirement, you may be subject to taxes -- and this often
Great News for Plug Power Stock Investors
Fool.com contributor Parkev Tatevosian discusses the ambitious outlook from Plug Power (NASDAQ: PLUG) management and what it could mean for Plug stock investors.
*Stock prices used were the
Why WW International Stock Was Bulking Up This Week
According to data compiled by S&P Global Market Intelligence, veteran dieting services company WW International's (NASDAQ: WW) stock was up by more than 7% week to date as of late Thursday. It
The 2 Stocks Everyone's Watching Thursday Night
Stocks were generally lower on Thursday, with major market benchmarks giving up early gains. Losses for the Nasdaq Composite (NASDAQINDEX: ^IXIC), Dow Jones Industrial Average (DJINDICES: ^DJI), and
Chinese EV Suppliers Look to Tap US Market With a Little Help From Friends
For more crisp and insightful business and economic news, subscribe to The Daily Upside newsletter It's completely free and we guarantee you'll learn something new every day.
China may have
Ikea Slashes Prices Amid Cooling Inflation
For more crisp and insightful business and economic news, subscribe to The Daily Upside newsletter It's completely free and we guarantee you'll learn something new every day.
Ikea's
Why Chewy Stock Got Thrashed on Thursday
In the latest of several such moves in recent weeks, Chewy (NYSE: CHWY) was hit with another analyst price target cut on Thursday. This rattled investor confidence in the stock, and the market
Why Evolv Technologies Stock Tumbled by 13% Today
Security tech stock Evolv Technologies Holdings (NASDAQ: EVLV) was hardly looking like a secure investment on Thursday. The company's share price fell by more than 13% after management published a
Why AT&T Stock Slumped Today
AT&T (NYSE: T) wasn't headed into the weekend on a high note. On Thursday, the incumbent telecom stock lost 2% of its value, not least because a pundit reduced his price target. That decline was
Why Shares of Insulet Dropped This Week
Shares of Insulet (NASDAQ: PODD) were down 12.2% for the week as of Thursday's close, according to data provided by S&P Global Market Intelligence. The healthcare stock closed last week at $145.51
Why Hormel Stock Dropped 10% Today
Shares of Hormel Foods (NYSE: HRL) were taking a dive after the normally solid consumer staples stock disappointed the market with its long-term forecast and struck a deal with its union to pay
Why NextEra Energy Partners, Tellurian, and Medical Properties Trust Plunged Today
Shares of NextEra Energy Partners (NYSE: NEP), Tellurian (NYSE: TEL), and Medical Properties Trust (NYSE: MPW) sank today, falling 7%, 9.5%, and 4.1%, respectively, in today's trading.
NextEra
Why Akero Therapeutics Shares Are Slumping This Week
Shares of Akero Therapeutics (NASDAQ: AKRO) were down more than 70% for the week as of Thursday's close, according to data provided by S&P Global Market Intelligence. The healthcare stock closed
Why Scholar Rock Holding Stock Soared Today
Shares of Scholar Rock Holding Corp. (NASDAQ: SRRK) skyrocketed as much as 35% early Thursday, then settled to trade up 13.7% as of 3 p.m. ET after the company announced an expansion into treatments
Why JD.com Sank Today
Shares of Chinese e-commerce leader JD.com (NASDAQ: JD) sank today, falling 8.3% as of 1:28 p.m. ET.
JD.com has been battered this year amid a sluggish recovery in the Chinese economy after COVID-19
Why Shares of ProKidney Were Dropping Thursday
Shares of ProKidney (NASDAQ: PROK) were down more than 33% as of 2 p.m. ET on Thursday. The healthcare stock is down more than 64% so far this year.
ProKidney is a clinical-stage biotech company


